Literature DB >> 20106472

A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients.

Daniele Soria1, Jonathan M Garibaldi, Federico Ambrogi, Andrew R Green, Des Powe, Emad Rakha, R Douglas Macmillan, Roger W Blamey, Graham Ball, Paulo J G Lisboa, Terence A Etchells, Patrizia Boracchi, Elia Biganzoli, Ian O Ellis.   

Abstract

Single clustering methods have often been used to elucidate clusters in high dimensional medical data, even though reliance on a single algorithm is known to be problematic. In this paper, we present a methodology to determine a set of 'core classes' by using a range of techniques to reach consensus across several different clustering algorithms, and to ascertain the key characteristics of these classes. We apply the methodology to immunohistochemical data from breast cancer patients. In doing so, we identify six core classes, of which several may be novel sub-groups not previously emphasised in literature. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20106472     DOI: 10.1016/j.compbiomed.2010.01.003

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  14 in total

1.  Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.

Authors:  Arvydas Laurinavicius; Aida Laurinaviciene; Valerijus Ostapenko; Darius Dasevicius; Sonata Jarmalaite; Juozas Lazutka
Journal:  Diagn Pathol       Date:  2012-03-16       Impact factor: 2.644

2.  Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Zihe Zheng; Sushrut S Waikar; Insa M Schmidt; J Richard Landis; Chi-Yuan Hsu; Tariq Shafi; Harold I Feldman; Amanda H Anderson; Francis P Wilson; Jing Chen; Hernan Rincon-Choles; Ana C Ricardo; Georges Saab; Tamara Isakova; Radhakrishna Kallem; Jeffrey C Fink; Panduranga S Rao; Dawei Xie; Wei Yang
Journal:  J Am Soc Nephrol       Date:  2021-01-18       Impact factor: 14.978

3.  Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers.

Authors:  A R Green; D G Powe; E A Rakha; D Soria; C Lemetre; C C Nolan; F F T Barros; R D Macmillan; J M Garibaldi; G R Ball; I O Ellis
Journal:  Br J Cancer       Date:  2013-09-05       Impact factor: 7.640

4.  Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer.

Authors:  E A Rakha; D Soria; A R Green; C Lemetre; D G Powe; C C Nolan; J M Garibaldi; G Ball; I O Ellis
Journal:  Br J Cancer       Date:  2014-03-11       Impact factor: 7.640

5.  Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.

Authors:  Andrew R Green; Daniele Soria; Jacqueline Stephen; Desmond G Powe; Christopher C Nolan; Ian Kunkler; Jeremy Thomas; Gillian R Kerr; Wilma Jack; David Cameron; Tammy Piper; Graham R Ball; Jonathan M Garibaldi; Emad A Rakha; John Ms Bartlett; Ian O Ellis
Journal:  J Pathol Clin Res       Date:  2016-01-15

6.  Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma.

Authors:  Arvydas Laurinavicius; Andrew R Green; Aida Laurinaviciene; Giedre Smailyte; Valerijus Ostapenko; Raimundas Meskauskas; Ian O Ellis
Journal:  Oncotarget       Date:  2015-12-01

7.  MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.

Authors:  Madeleine L Craze; Hayley Cheung; Natasha Jewa; Nuno D M Coimbra; Daniele Soria; Rokaya El-Ansari; Mohammed A Aleskandarany; Kiu Wai Cheng; Maria Diez-Rodriguez; Christopher C Nolan; Ian O Ellis; Emad A Rakha; Andrew R Green
Journal:  Br J Cancer       Date:  2017-11-23       Impact factor: 7.640

8.  Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts.

Authors:  B M Syed; A R Green; E C Paish; D Soria; J Garibaldi; L Morgan; D A L Morgan; I O Ellis; K L Cheung
Journal:  Br J Cancer       Date:  2013-03-05       Impact factor: 7.640

9.  Classification of patients with breast cancer according to Nottingham prognostic index highlights significant differences in immunohistochemical marker expression.

Authors:  Fisnik Kurshumliu; Lumturije Gashi-Luci; Shahin Kadare; Mehdi Alimehmeti; Ugur Gozalan
Journal:  World J Surg Oncol       Date:  2014-08-01       Impact factor: 2.754

10.  Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer.

Authors:  Andrew R Green; D Soria; D G Powe; C C Nolan; M Aleskandarany; M A Szász; A M Tőkés; G R Ball; J M Garibaldi; E A Rakha; J Kulka; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  2016-04-26       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.